BioSpace News Archive

MacroGenics, Inc., a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced that the Company’s management will participate in the following conferences in November and December 2021:

Ortho Clinical Diagnostics Holdings plc today announced financial results for the third quarter ended October 3, 2021.

Tyra Biosciences, Inc. today reported financial results for the quarter ended September 30, 2021

Sonendo, Inc. today announced the appointment of three new members to its Board of Directors.

Illumina Inc. announced that its world-class sequencing and bioinformatics solutions are being used by HostSeq, part of the Canadian COVID-19 Genomics Network, to identify biomarkers that can help predict potential risk of serious disease and support the development of novel therapeutics to combat COVID-19.

10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2021.

Trevi Therapeutics, Inc. today announced that management will host a conference call and live audio webcast on Wednesday, November 10 at 4:30 p.m. ET, to provide a corporate update and review the Company’s financial results for the third quarter ended September 30, 2021.

Penumbra, Inc. today reported financial results for the third quarter ended September 30, 2021 .

Outset Medical, Inc. today reported financial results for the third quarter ended September 30, 2021.

STAAR Surgical Company today reported financial results for the third quarter ended October 1, 2021.